Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
OrthoPediatrics Corp. - Common Stock
(NQ:
KIDS
)
23.09
+0.91 (+4.10%)
Streaming Delayed Price
Updated: 3:51 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about OrthoPediatrics Corp. - Common Stock
< Previous
1
2
Next >
Demystifying OrthoPediatrics: Insights From 7 Analyst Reviews
Today 9:00 EDT
Via
Benzinga
Earnings Scheduled For May 7, 2025
May 07, 2025
Via
Benzinga
Analyst Expectations For OrthoPediatrics's Future
April 11, 2025
Via
Benzinga
Demystifying OrthoPediatrics: Insights From 4 Analyst Reviews
March 21, 2025
Via
Benzinga
The Latest Analyst Ratings For OrthoPediatrics
November 08, 2024
Via
Benzinga
The Latest Analyst Ratings For OrthoPediatrics
September 13, 2024
Via
Benzinga
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Expert Ratings For OrthoPediatrics
May 07, 2024
Via
Benzinga
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
April 10, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
March 07, 2024
Via
Benzinga
Earnings Scheduled For March 4, 2025
March 04, 2025
Via
Benzinga
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Recap: OrthoPediatrics Q4 Earnings
March 06, 2024
Via
Benzinga
Earnings Outlook For OrthoPediatrics
March 05, 2024
Via
Benzinga
Decoding 5 Analyst Evaluations For OrthoPediatrics
January 25, 2024
Via
Benzinga
Analyst Ratings for OrthoPediatrics
December 07, 2023
Via
Benzinga
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
March 07, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Misses Revenue for Q4 2023
March 06, 2024
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
October 04, 2023
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell...
Via
Benzinga
4 Analysts Have This to Say About OrthoPediatrics
September 01, 2023
Via
Benzinga
OrthoPediatrics's Earnings: A Preview
July 28, 2023
Via
Benzinga
Analyst Ratings for OrthoPediatrics
May 02, 2023
Via
Benzinga
OrthoPediatrics's Earnings Outlook
April 28, 2023
Via
Benzinga
Analyst Expectations for OrthoPediatrics's Future
January 10, 2023
Via
Benzinga
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Where OrthoPediatrics Stands With Analysts
November 02, 2022
OrthoPediatrics (NASDAQ:KIDS) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Earnings Scheduled For July 31, 2023
July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via
Benzinga
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
Respiratory Infections Led OrthoPediatrics Miss Quarterly Sales Expectations, Analyst Calls It Transitory Issue
January 10, 2023
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.